- Home
- GDV vs IDYA Comparison
GDV vs IDYA Comparison
Compare GDV & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDV
- IDYA
- Stock Information
- Founded
- GDV 2003
- IDYA 2015
- Country
- GDV United States
- IDYA United States
- Employees
- GDV N/A
- IDYA N/A
- Industry
- GDV Investment Managers
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- GDV Finance
- IDYA Health Care
- Exchange
- GDV Nasdaq
- IDYA Nasdaq
- Market Cap
- GDV 2.3B
- IDYA 2.6B
- IPO Year
- GDV N/A
- IDYA 2019
- Fundamental
- Price
- GDV $24.48
- IDYA $26.94
- Analyst Decision
- GDV
- IDYA Strong Buy
- Analyst Count
- GDV 0
- IDYA 12
- Target Price
- GDV N/A
- IDYA $53.67
- AVG Volume (30 Days)
- GDV 186.0K
- IDYA 997.6K
- Earning Date
- GDV 01-01-0001
- IDYA 11-04-2024
- Dividend Yield
- GDV 5.81%
- IDYA N/A
- EPS Growth
- GDV N/A
- IDYA N/A
- EPS
- GDV N/A
- IDYA N/A
- Revenue
- GDV N/A
- IDYA $3,922,000.00
- Revenue This Year
- GDV N/A
- IDYA N/A
- Revenue Next Year
- GDV N/A
- IDYA $251.89
- P/E Ratio
- GDV N/A
- IDYA N/A
- Revenue Growth
- GDV N/A
- IDYA N/A
- 52 Week Low
- GDV $18.04
- IDYA $24.72
- 52 Week High
- GDV $23.00
- IDYA $47.74
- Technical
- Relative Strength Index (RSI)
- GDV 39.30
- IDYA 45.25
- Support Level
- GDV $24.56
- IDYA $24.72
- Resistance Level
- GDV $25.65
- IDYA $26.86
- Average True Range (ATR)
- GDV 0.19
- IDYA 1.23
- MACD
- GDV -0.12
- IDYA 0.04
- Stochastic Oscillator
- GDV 7.66
- IDYA 46.89
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food & Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.